Guselkumab Shows Similar Domain-Specific Efficacy in Females and Males with Active Psoriatic Arthritis: Post Hoc Analyses of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies

被引：0
作者：
Eder, Lihi [1 ,2 ]
Selmi, Carlo [3 ]
Mease, Philip [4 ,5 ]
Ogdie, Alexis [6 ]
Nantel, Francois [7 ]
Lavie, Frederic [8 ]
Sharaf, Mohamed [9 ]
Adelakun, Oyediran [10 ]
Rampakakis, Emmanouil [11 ]
Vegas, Laura Pina [12 ]
Coates, Laura [13 ]
机构：
[1] Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada
[2] Dept Med, Toronto, ON, Canada
[3] IRCCS Ist Clin Humanitas, Rozzano, Italy
[4] Providence St Joseph, Swedish Med Ctr, Seattle, WA USA
[5] Univ Washington, Sch Med, Seattle, WA USA
[6] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA
[7] Nantel MedSci Consult, Montreal, PQ, Canada
[8] Janssen Cilag Global Med Affairs, Immunol Global Med Affairs, Issy Les Moulineaux, France
[9] Middle East FZ LLC, Johnson & Johnson, Dubai, U Arab Emirates
[10] Janssen Res Dev LLC, Titusville, NJ USA
[11] McGill Univ, Dept Pediat Sci Affairs, JSS Med Res Inc, Montreal, PQ, Canada
[12] Leiden Univ, Med Ctr, Leiden, Netherlands
[13] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2342
引用
收藏
页码：4720 / 4722
页数：3
相关论文
共 50 条
  • [31] Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study
    Schett, Georg
    Wollenhaupt, Jurgen
    Papp, Kim
    Joos, Rik
    Rodrigues, Jude F.
    Vessey, Adele R.
    Hu, ChiaChi
    Stevens, Randall
    de Vlam, Kurt L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : 3156 - 3167
  • [32] GUSELKUMAB EFFICACY IN ADULT PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS BY BASELINE DEMOGRAPHIC AND DISEASE CHARACTERISTICS: POOLED RESULTS OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
    Deodhar, Atul
    Mease, Philip J.
    Boencke, Wolf-Henning
    Tesser, John
    Schiopu, Elena
    Chakravarty, Soumya D.
    Kollmeier, Alexa P.
    Hsia, Elizabeth C.
    Xu, Xie L.
    Shawi, May
    Jiang, Yusang
    Sheng, Shihong
    Agarwal, Prasheen
    Merola, Joseph F.
    McInnes, Iain B.
    Ritchlin, Christopher T.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S108 - S109
  • [33] Guselkumab Efficacy in Adult Patients with Active Psoriatic Arthritis by Baseline Demographic and Disease Characteristics: Pooled Results of Two Phase 3, Randomized, Placebo-Controlled Studies
    Deodhar, Atul
    Mease, Philip
    Boehncke, Wolf-Henning
    Tesser, John
    Schiopu, Elena
    Chakravarty, Soumya
    Kollmeier, Alexa
    Hsia, Elizabeth
    Xu, Xie
    Shawi, May
    Jiang, Yusang
    Sheng, Shihong
    Agarwal, Prasheen
    Merola, Joseph
    McInnes, Iain
    Ritchlin, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [34] Efficacy and safety of brexpiprazole in schizophrenia: Meta-analysis of three double-blind, randomized, placebo-controlled phase 3 studies
    Weiss, C.
    Zhang, P.
    Hakala, M. J.
    Skuban, A.
    Weiller, E.
    EUROPEAN PSYCHIATRY, 2016, 33 : S109 - S109
  • [35] Safety of efalizumab in patients with psoriatic arthritis: Results of a phase II, randomized, double-blind, placebo-controlled study
    Papp, K
    Mease, P
    Garovoy, M
    Zhang, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P156 - P156
  • [36] Efficacy of cariprazine in bipolar depression: post hoc band-pass analyses of two randomized, double-blind, placebo-controlled trials
    Yatham, L.
    Vieta, E.
    Durgam, S.
    Earley, W.
    Lu, K.
    Laszlovszky, I.
    Nemeth, G.
    BIPOLAR DISORDERS, 2016, 18 : 182 - 182
  • [37] Ustekinumab in Patients with Active Psoriatic Arthritis: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Psummit I Study
    Kavanaugh, Arthur
    McInnes, Iain B.
    Gottlieb, Alice B.
    Puig, Lluis
    Rahman, Proton
    Ritchlin, Christopher T.
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Doyle, Mittie K.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1083 - S1084
  • [38] USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF THE PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PSUMMIT I STUDY
    McInnes, I. B.
    Kavanaugh, A.
    Gottlieb, A. B.
    Puig, L.
    Rahman, P.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Doyle, M. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 107 - 107
  • [39] Stringent Disease Activity Control at 2 Years Across Psoriatic Arthritis Domains Irrespective of Baseline Characteristics in Patients Treated with Guselkumab: Post-Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
    Ritchlin, Christopher T.
    Mease, Philip J.
    Boehncke, Wolf-Henning
    Tesser, John
    Chakravarty, Soumya D.
    Rampakakis, Emmanouil
    Shawi, May
    Merola, Joseph F.
    McInnes, Iain B.
    Deodhar, Atul
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB225 - AB225
  • [40] Alefacept in combination with methotrexate for treatment of active psoriatic arthritis: Rationale and design of a randomized, double-blind, placebo-controlled study
    Gladman, D
    Keystone, E
    Gottlieb, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P60 - P60
12345